1. Mast Cells and Proteins Related to Myofibroblast Differentiation (PAR-2, IL-6, and TGFβ1) in Salivary Cancers: A Preliminary Study
   Adna B. Ismerim et al, 2021, Applied Immunohistochemistry & Molecular Morphology CrossRef
2. Protease-activated receptor 2 enhances renal cell carcinoma cell invasion and migration via PI3K/AKT signaling pathway
   Zhixia Sun et al, 2015, Experimental and Molecular Pathology CrossRef
3. Synthetic Indolactam V Analogues as Inhibitors of PAR2‐Induced Calcium Mobilization in Triple‐Negative Breast Cancer Cells
   Jan Stein et al, 2018, ChemMedChem CrossRef
4. GPCRs in pancreatic adenocarcinoma: Contributors to tumour biology and novel therapeutic targets
   Krishna Sriram et al, 2020, British Journal of Pharmacology CrossRef
5. Protease-activated receptors (PARs)—biology and role in cancer invasion and metastasis
   Marek Z. Wojtukiewicz et al, 2015, Cancer and Metastasis Reviews CrossRef
6. Teleocidin A2 inhibits human proteinase‐activated receptor 2 signaling in tumor cells
   Sonja Stahn et al, 2016, Pharmacology Research & Perspectives CrossRef
7. PAR2: The Cornerstone of Pancreatic Diseases
   P SUHAJ et al, 2022, Physiological Research CrossRef
8. Upamostat: a serine protease inhibitor for antiviral, gastrointestinal, and anticancer indications
   TF. Plasse et al, 2023, Expert Opinion on Investigational Drugs CrossRef
9. Is There a Trojan Horse to Aggressive Pancreatic Cancer Biology? A Review of the Trypsin-PAR2 Axis to Proliferation, Early Invasion, and Metastasis
   Kjetil Søreide et al, 2020, Journal of Pancreatic Cancer CrossRef
10. PAR-2 promotes cell proliferation, migration, and invasion through activating PI3K/AKT signaling pathway in oral squamous cell carcinoma
    Kai-Liang Tang et al, 2019, Bioscience Reports CrossRef
11. Edoxaban, a Factor Xa-Specific Direct Oral Anticoagulant, Significantly Suppresses Tumor Growth in Colorectal Cancer Colon26-Inoculated BALB/c Mice
    Keiichi Hiramoto et al, 2023, TH Open CrossRef
12. A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells
    Yuhong Jiang et al, 2018, Journal of Pharmacology and Experimental Therapeutics CrossRef